Lenalidomide oral monotherapy produces a high response rate in patients with relapsed or refractory mantle cell lymphoma

Thomas M. Habermann, Izidore S. Lossos, Glen Justice, Julie M. Vose, Peter H. Wiernik, Kyle McBride, Kenton Wride, Annette Ervin-Haynes, Kenichi Takeshita, Dennis Pietronigro, Jerome B. Zeldis, Joseph M. Tuscano

Research output: Contribution to journalArticlepeer-review

210 Scopus citations

Fingerprint Dive into the research topics of 'Lenalidomide oral monotherapy produces a high response rate in patients with relapsed or refractory mantle cell lymphoma'. Together they form a unique fingerprint.

Medicine & Life Sciences